Amplitude Ventures related stories
All articles and analysis
Notch Therapeutics brings in $85m in Series A roundVancouver-based biotechnology company Notch Therapeutics has raised $85 million in a Series A financing.
- Amplitude amasses C$50m-plus more for C$200m-targeted fund
Amplitude Venture Capital raised more than C$50 million in the second close of its debut precision medicine fund, bringing it to more than 75 percent of its C$200 million target.
VC-backed Repare Therapeutics closes Nasdaq IPO, raises $253mRepare Therapeutics, a Boston- and Montreal-based precision oncology company, has closed its initial public offering on the NASDAQ.
- VC-backed Repare Therapeutics goes public, raises $220m
Repare Therapeutics, a Boston- and Montreal-based precision oncology company, has raised about US$220 million for its IPO after pricing its 11 million shares at US$20 per share.
InvestEco wraps up third sustainable food fundToronto-based InvestEco Capital has closed its third sustainable food fund at C$100 million.
- VC-backed InnerSpace promotes Goodall to president and COO
Toronto-based InnerSpace, an indoor location intelligence platform, has promoted Cerys Goodall to president and chief operating officer.
Former Evernote chairman Chris O'Neill joins Canadian firm Portag3Based in San Francisco, O' Neill will focus on expanding the geographic reach of the Canadian firm into Silicon Valley.
- Amplitude unveils $200 mln fund
Amplitude Venture Capital has launched a $200 million fund. So far, the fund has raised 50 percent of its target. The fund will invest in Canadian healthcare companies. Amplitude was co-created with cornerstone investor BDC Capital.
Canada's Amplitude more than halfway to final close on debut fundThe BDC spin-out has raised over half of the C$200 ($152 million) target for its first fund.
